Microglial heterogeneity in aging and Alzheimer's disease: Is sex relevant?

Charlotte Isabelle Delage1, Eva Šimončičová1, Marie-Ève Tremblay2

  • 1Division of Medical Sciences, University of Victoria, Victoria, Canada.

Insights

Microglia, the brain's immune cells, play a role in neurodegenerative diseases like Alzheimer's. This review examines how microglial heterogeneity and sex differences impact aging and Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Neurodegenerative diseases, including Alzheimer's disease (AD), are more common with aging and exhibit a sex bias, with females at higher risk.
  • Microglia, the brain's resident immune cells, are increasingly implicated in the pathogenesis of neurodegenerative conditions.
  • Emerging evidence highlights the heterogeneity of microglial populations and potential sex-based differences in their function.

Purpose of the Study:

  • To review the concept of microglial heterogeneity during aging.
  • To explore sex differences in microglial function in both healthy aging and Alzheimer's disease.
  • To synthesize current understanding of how these factors interact in neurodegeneration.

Main Methods:

  • Literature review of recent studies on microglia, aging, sex differences, and Alzheimer's disease.
  • Analysis of research investigating microglial phenotypes and heterogeneity.
  • Synthesis of findings related to sex-based disparities in microglial responses.

Main Results:

  • Microglia are not a uniform population; they exhibit diverse phenotypes influenced by age and sex.
  • Sex differences in microglia may contribute to the higher prevalence of AD in females.
  • Aging alters microglial characteristics, potentially exacerbating disease-related changes.

Conclusions:

  • Microglial heterogeneity and sex differences are critical factors in understanding aging and Alzheimer's disease.
  • Further research into sex-specific microglial biology is needed to develop targeted therapies.
  • Addressing these differences could lead to more effective strategies for preventing and treating AD.